NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Hepatocellular carcinoma (HCC) develops on the background of chronic hepatitis. Leukocytes found within the HCC microenvironment are implicated as regulators of tumour growth. We show that diethylnitrosamine (DEN)-induced murine HCC is attenuated by antibody-mediated depletion of hepatic neutrophils, the latter stimulating hepatocellular ROS and telomere DNA damage. We additionally report a previously unappreciated tumour suppressor function for hepatocellular nfkb1 operating via p50:p50 dimers and the co-repressor HDAC1. These anti-inflammatory proteins combine to transcriptionally repress hepatic expression of a S100A8/9, CXCL1 and CXCL2 neutrophil chemokine network. Loss of nfkb1 promotes ageing-associated chronic liver disease (CLD), characterized by steatosis, neutrophillia, fibrosis, hepatocyte telomere damage and HCC. Nfkb1 S340A/S340A mice carrying a mutation designed to selectively disrupt p50:p50:HDAC1 complexes are more susceptible to HCC; by contrast, mice lacking S100A9 express reduced neutrophil chemokines and are protected from HCC. Inhibiting neutrophil accumulation in CLD or targeting their tumour-promoting activities may offer therapeutic opportunities in HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and hepatocellular carcinoma (65).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased hepatocyte Snc burden is observed during aging and obesity in mice (15) and in chronic parenchymal liver disorders in humans such as chronic viral hepatitis (66), alcohol-related liver disease (65), NAFLD (15, 67), and genetic hemochromatosis (68).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alcoholic liver disease and chronic viral hepatitis have also been associated with telomere dysfunction in human liver biopsies100,101.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [101]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Cellular senescence is implicated in the progression of liver disease.”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [65]
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, the expression of CDKN1A, CDKN2A and the presence of TAF has been found in the context of non-alcoholic fatty liver disease159,161, and TAF have been reported in livers from individuals with alcoholic liver disease162.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Knowledge‐based protein secondary structure assignment
Frishman, D., & Argos, P. (1995) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340230412 · Cited by 2,523
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Self-citationNeutrophil Function: From Mechanisms to Disease
Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., & Zychlinsky, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074942 · Cited by 1,708
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice
Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S., & Albina, J. E. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407247 · Cited by 1,046
The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1
Zhong, H., May, M. J., Jimi, E., & Ghosh, S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00477-x · Cited by 939
Cited by
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612
“For instance, neutrophil-derived ROS damages hepatocyte DNA to drive HCC development.(314) Neutrophils can eliminate bacteria from the body, forming an immune barrier that allows cancers to start growing back;(315,316) therefore, they are closely correlated with prognostic outcomes of cancer patients.”
BackgroundFrom NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Neutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Cellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044
Self-citationThe role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Self-citationThe Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
“As such, neutrophils promote the development of HCC (58) but do not appear to exert a role in hepatic fibrogenesis (59, 60).”
BackgroundThe Regulation of NF-κB Subunits by Phosphorylation
Christian, F., Smith, E., & Carmody, R. (2016) · Cells · doi:10.3390/cells5010012 · Cited by 717
“In addition to the above phosphorylation sites of p50, an additional serine residue of p50, S340, has been recently shown to be important for the formation of p50 homodimers [31].”
BackgroundSenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
“expression of CDKN1A , CDKN2A and the presence of TAF has been found in the context of non-alcoholic fatty liver disease 159,161 , and TAF have been reported in livers from individuals with alcoholic liver disease 162 .”
Self-citationNFKB1: a suppressor of inflammation, ageing and cancer
Cartwright, T., Perkins, N. D., & L. Wilson, C. (2016) · The FEBS Journal · doi:10.1111/febs.13627 · Cited by 347
Self-citationBaglieri, J., Brenner, D. A., & Kisseleva, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071723 · Cited by 341
Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span
Robbins, P. D., Jurk, D., Khosla, S., Kirkland, J. L., LeBrasseur, N. K., Miller, J. D., Passos, J. F., Pignolo, R. J., Tchkonia, T., & Niedernhofer, L. J. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-050120-105018 · Cited by 360
“Furthermore, chronic inflammation driven by the SASP spreads hepatocyte senescence, contributing to liver fibrosis (64) and hepatocellular carcinoma (65).”
BackgroundSelf-citationNeutrophils as potential therapeutic targets in hepatocellular carcinoma
Geh, D., Leslie, J., Rumney, R., Reeves, H. L., Bird, T. G., & Mann, D. A. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00568-5 · Cited by 218
Self-citationNeutrophils induce paracrine telomere dysfunction and senescence in ROS‐dependent manner
Lagnado, A., Leslie, J., Ruchaud‐Sparagano, M., Victorelli, S., Hirsova, P., Ogrodnik, M., Collins, A. L., Vizioli, M. G., Habiballa, L., Saretzki, G., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106048 · Cited by 211
“In the context of the liver, hepatocytes containing dysfunctional telomeres have been shown to increase during aging in mice (Hewitt et al, 2012) and also in alcoholic liver disease (ALD) (Wilson et al, 2015) and non-alcoholic fatty liver disease (NAFLD) (Ogrodnik et al, 2017) patients.”
Self-citationWang, H., Liang, L., Dong, Q., Huan, L., He, J., Li, B., Yang, C., Jin, H., Wei, L., Yu, C., et al. (2018) · Theranostics · doi:10.7150/thno.23012 · Cited by 186
“Aberrant activation of the NF-κB signaling pathway is known to be associated with a wide range of cancers, including HCC [20-22].”
Hypoxia-inducible factors and innate immunity in liver cancer
Yuen, V. W.-H., & Wong, C. C.-L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137553 · Cited by 183
“Depleting neutrophils activates CD8+ T cells and represses HCC growth (66, 67).”
BackgroundMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
“A previous study using the same nfkb1−/ − mice reported increased frequencies of hepatocytes harboring telomere damage, a major hallmark of senescent cells, in hepatocellular carcinoma, which could be reduced upon neutrophil-specific depletion (Wilson et al., 2015).”
BackgroundSelf-citationRoles of reactive oxygen species in inflammation and cancer
Yu, Y., Liu, S., Yang, L., Song, P., Liu, Z., Liu, X., Yan, X., & Dong, Q. (2024) · MedComm · doi:10.1002/mco2.519 · Cited by 164
“127,128 Neutrophils can activate certain carcinogens, such as benzopyrene, afla-toxins, and quartz particles, thereby exacerbating genomic instability.”
BackgroundRole of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models
García-García, V. A., Alameda, J. P., Page, A., & Casanova, M. L. (2021) · Cells · doi:10.3390/cells10081906 · Cited by 161
“Thus, the use of Nfkb1deficient mice has established the role of p50 in the development of ageing associated chronic liver disease (CLD), with hepatocyte telomere damage, dysplasia, and HCC development [65,160] (Tables 1 and 4).”
BackgroundSelf-citationReactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
Yu, W., Tu, Y., Long, Z., Liu, J., Kong, D., Peng, J., Wu, H., Zheng, G., Zhao, J., Chen, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2606928 · Cited by 161
“In DEN-treated mice, the accumulation of hepatic neutrophils stimulates hepatocellular ROS generation and telomere DNA damage, which is ameliorated by antioxidant agents [117].”
InfluentialAntuamwine, B. B., Bosnjakovic, R., Hofmann-Vega, F., Wang, X., Θεοδοσίου, Θ., Iliopoulos, I., & Brandau, S. (2022) · Immunological Reviews · doi:10.1111/imr.13176 · Cited by 177
Korbecki, J., Barczak, K., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020792 · Cited by 173
“In hepatocytes, there is an important NF-κB p50/p50 homodimer that binds to the CXCL1 promoter to recruit the co-repressor histone deacetylase 1 (HDAC1) [49].”
BackgroundHepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD
Reeves, H. L., Zaki, M. Y. W., & Day, C. P. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4085-6 · Cited by 166
NFKB1 and Cancer: Friend or Foe?
Concetti, J., & Wilson, C. L. (2018) · Cells · doi:10.3390/cells7090133 · Cited by 154
“Interestingly, in a non-experimentally-induced context, aged 20 month old Nfkb1−/− mice also develop spontaneous chronic liver disease and liver cancer characterised by dysplastic nodules, increased tumour incidence, features of steatohepatitis and fibrosis [23].”
BackgroundSelf-citationNeutrophil dynamics in the tumor microenvironment
McFarlane, A. J., Fercoq, F., Coffelt, S. B., & Carlin, L. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143759 · Cited by 138
“However, ROS production by neutrophils can also play a role in cancer cell killing (20, 24, 45, 46), but the context in which ROS are protumor or antitumor remains unresolved.”
BackgroundInfluentialNeutrophils in cancer development and progression: Roles, mechanisms, and implications (Review)
Zhang, X., Zhang, W., Yuan, X., Fu, M., Qian, H., & Xu, W. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3616 · Cited by 143
Esparza-Baquer, A., Labiano, I., Sharif, O., Lizaso, A. A., Oakley, F., Rodrigues, P. M., Zhuravleva, E., O’Rourke, C. J., Hijona, E., Jiménez-Agüero, R., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319227 · Cited by 140
Self-citationTumor-Associated Neutrophils and Macrophages—Heterogenous but Not Chaotic
Wu, L., & Zhang, X. H.-F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.553967 · Cited by 135
“Anti-oxidant treatment led to protection against progression of DEN induced hepatocellular carcinoma (22).”
BackgroundEngineering and Targeting Neutrophils for Cancer Therapy
Zhang, J., Gu, J., Wang, X., Ji, C., Yu, D., Wang, M., Pan, J., Santos, H. A., Zhang, H., & Zhang, X. (2024) · Advanced Materials · doi:10.1002/adma.202310318 · Cited by 129
Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity
Zhou, Y., Shen, G., Zhou, X., & Li, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02242-7 · Cited by 149
“275 Furthermore, the functional plasticity of peripheral neutrophils in tumors is evident, with G-CSF involved in mobilizing immature LDNs. 62 For instance, in OSCC patients, LDNs show signi fi cantly increased IL-17 expression compared to NDNs, and the LDNs/NDNs ratio is also considerably higher compared to healthy pe…”
HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
Hernandez, C., Huebener, P., Pradere, J.-P., Antoine, D. J., Friedman, R. A., & Schwabe, R. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci91786 · Cited by 110
“Likewise, we did not find a role for HMGB1 in the recruitment of neutrophils (Figure 8D), a cell population that contributes to the development of liver cancer (60) and whose numbers positively correlate with worse prognosis in HCC (61, 62).”
BackgroundYeh, Y.-H., Hsiao, H.-F., Yeh, Y.-C., Chen, T.-W., & Li, T. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0730-6 · Cited by 114
“Similar to HIF-1α, NF-κB is a master transcription factor (TF) inducing expression of diverse target gene sets, thus playing an instrumental role in immune, stress and pathological inflammatory TME responses [44].”
BackgroundRoles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer
Markopoulos, G. S., Roupakia, E., Tokamani, M., Alabasi, G., Sandaltzopoulos, R., Marcu, K. B., & Kolettas, E. (2018) · Biomedicines · doi:10.3390/biomedicines6020040 · Cited by 127
“Nfkb1(p105/p50)-/- mice display increased inflammation and susceptibility to DNA damaging agents, leading to cancer including lymphomas and liver cancer, and an ageing phenotype [55,126,127].”
BackgroundDu, K., Li, Y., Liu, J., Chen, W., Wei, Z., Luo, Y., Liu, H., Qi, Y., Wang, F., & Sui, J. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.006 · Cited by 114
“Interestingly, there are also reports of neutrophil involvement in HCC progression.(34,35) Thus, it will be interesting to examine whether and how neutrophils contribute to GPC3/CD47 biAb’s antitumor effects in HCC patients.”
BackgroundNeutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
Margetts, J., Ogle, L. F., Chan, S. L., Chan, A. W. H., Chan, K. C. A., Jamieson, D., Willoughby, C. E., Mann, D. A., Wilson, C. L., Manas, D., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.386 · Cited by 123
“Our recent work in an animal model of DEN-induced HCC highlights a potential role in promoting cancer growth, as neutrophil depletion in advanced stage disease reduced tumour burden (Wilson et al, 2015).”
BackgroundSelf-citationTwo Faces of Neutrophils in Liver Disease Development and Progression
Cho, Y., & Szabo, G. (2021) · Hepatology · doi:10.1002/hep.31680 · Cited by 97
Epigenetic reprogramming in liver fibrosis and cancer
Wilson, C. L., Mann, D. A., & Borthwick, L. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.011 · Cited by 96
“More recentlywe showed that aged mice lacking p50 succumb to spontaneous fibrosis [60].”
Self-citationCurrent and emerging strategies for the prevention of hepatocellular carcinoma
Yeo, Y. H., Abdelmalek, M. F., Khan, S. A., Moylan, C. A., Rodriquez, L. M., Villanueva, A., & Yang, J. D. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01021-z · Cited by 111
“A study published in 2015 indicated that hepatocellular NFKB1 serves as a tumour suppressor by suppressing overexpression of proteins that form a hepatic neutrophil chemokine network (S100A8/9, CXCL1 and CXCL2), thereby hindering HCC carcinogenesis 235 .”
Bladder cancer, inflammageing and microbiomes
Martin, A., Woolbright, B. L., Umar, S., Ingersoll, M. A., & Taylor, J. A. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00611-3 · Cited by 95
O’Reilly, L. A., Putoczki, T. L., Mielke, L. A., Low, J. T., Lin, A. E.-J., Preaudet, A., Herold, M. J., Yaprianto, K., Tai, L., Kueh, A. J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.003 · Cited by 97
Neutrophil Elastase and Neutrophil Extracellular Traps in the Tumor Microenvironment
Huang, H., Zhang, H., Onuma, A. E., & Tsung, A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-44518-8_2 · Cited by 105
Zhang, Q., Lou, Y., Bai, X., & Liang, T. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i31.3500 · Cited by 87
He, M., Zhang, W., Dong, Y., Wang, L., Fang, T., Tang, W., Lv, B., Chen, G., Yang, B., Huang, P., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0490-8 · Cited by 92
“Emerging evidence has demonstrated that perpetuating hepatic inflammation promotes HCC initiation and progression [13, 21, 22].”
BackgroundZhao, D., Zhang, Q., Liu, Y., Li, X., Zhao, K., Ding, Y., Li, Z., Shen, Q., Wang, C., Li, N., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.035 · Cited by 83
Rapamycin improves healthspan but not inflammaging in nfκb1−/− mice
Correia‐Melo, C., Birch, J., Fielder, E., Rahmatika, D., Taylor, J., Chapman, J., Lagnado, A., Carroll, B. M., Miwa, S., Richardson, G., et al. (2019) · Aging Cell · doi:10.1111/acel.12882 · Cited by 77
“…a mouse model showing premature aging phenotypes driven by genetically enhanced NF‐κB activation, the nfκb1 knockout (nfκb1−/−) mouse (Jurk et al., 2014; Wilson et al., 2015). nfκb1−/− mice have increased inflammation due to the absence of the NF‐κB1 (p50) subunit, which under normal conditions…”
BackgroundSelf-citationAnti‐inflammatory treatment rescues memory deficits during aging in nfkb1−/− mice
Fielder, E., Tweedy, C., Wilson, C., Oakley, F., LeBeau, F. E. N., Passos, J. F., Mann, D. A., von Zglinicki, T., & Jurk, D. (2020) · Aging Cell · doi:10.1111/acel.13188 · Cited by 71
“We found that nfkb1−/− mice, which have increased inflammation due to the absence of the NF-κB1 (p50) subunit, exhibit increased frequency of senescent cells and aging phenotypes in multiple organs and early mortality (Correia-Melo et al., 2019; Jurk et al., 2014; Wilson et al., 2015).”
BackgroundSelf-citationNiu, Z.-S., Wang, W., Dong, X., & Tian, L.-M.-L. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i29.4240 · Cited by 70
New-Onset Age of Nonalcoholic Fatty Liver Disease and Cancer Risk
Liu, C., Liu, T., Zhang, Q., Jia, P., Song, M., Zhang, Q., Ruan, G., Ge, Y., Lin, S., Wang, Z., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.35511 · Cited by 74
Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma
Elsegood, C. L., Tirnitz‐Parker, J. E. E., Olynyk, J. K., & Yeoh, G. C. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.47 · Cited by 66
“…prevent establishment of a chronic in fl ammatory environment that promotes cancer by inducing genetic instability and mutation in target cells 9,10 and (iii) eliminate tumour cells that often co-express ligands for activating innate immune cell receptors and tumour antigens that are recognised…”
BackgroundLiu, Y., Zhang, X., Chen, S., Wang, J., Yu, S., Li, Y., Xu, M. M., Aboubacar, H., Li, J., Shan, T., et al. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0039 · Cited by 64
“It has been reported that neutrophils contribute to ALD[27] and that antibody-mediated depletion of hepatic neutrophils will attenuate HCC[14].”
Roles of neutrophil reactive oxygen species (ROS) generation in organ function impairment in sepsis
Lu, J., Liu, J., & Li, A. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2101075 · Cited by 67
“Wilson et al. (2015) discovered that neutrophilgenerated ROS can damage liver telomere DNA, re‐ sulting in liver cancer and liver failure.”
BackgroundWang, Y., & Liu, Y. (2021) · Inflammation · doi:10.1007/s10753-021-01442-x · Cited by 71
A Review of CXCL1 in Cardiac Fibrosis
Wu, C., Yin, R., Wang, S., & Ying, R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.674498 · Cited by 65
“Excluding inflammation, CXCL1 is also active in angiogenesis, wound healing as well as tumorogenesis depending on interaction with leukocytes, endothelial cells, and fibroblasts (7, 15).”
BackgroundGrgurević, I., Božin, T., Mikuš, M., Kukla, M., & O’Beirne, J. P. (2021) · Cancers · doi:10.3390/cancers13225844 · Cited by 61
Wang, T., Zhou, Y., Zhou, Z., Zhang, P., Yan, R., Sun, L., Ma, W., Zhang, T., Shen, S., Liu, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37227-z · Cited by 64
Neutrophils: Driving inflammation during the development of hepatocellular carcinoma
Chen, H., Zhou, X.-H., Li, J., Zheng, T., Yao, F.-B., Gao, B., & Xue, T. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.011 · Cited by 54
Diverse Neutrophil Functions in Cancer and Promising Neutrophil-Based Cancer Therapies
Sounbuli, K., Mironova, N. L., & Alekseeva, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415827 · Cited by 55
The Role of Myeloid Cells in GBM Immunosuppression
Lin, Y.-J., Wu, C. Y.-J., Wu, J. Y., & Lim, M. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.887781 · Cited by 69
Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice
Koop, A. C., Thiele, N. D., Steins, D., Michaëlsson, E., Wehmeyer, M., Scheja, L., Steglich, B., Huber, S., Schulze zur Wiesch, J., Lohse, A. W., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1566 · Cited by 48
“(42) Several studies indicate that MPO and PMNs may play a role in hepatic carcinogenesis.(12,13,43,44) However, in our study, neither a mouse model of NASH-related HCC nor the NASH-independent MDR2 model showed any effects of MPO on HCC development, indicating that MPO is not the essential mediator of PMN-driven carc…”
BackgroundKoh, M. Y., Gagea, M., Sargis, T., Lemos, R., Grandjean, G., Charbono, A., Bekiaris, V., Sedy, J., Kiriakova, G., Liu, X., et al. (2016) · Hepatology · doi:10.1002/hep.28468 · Cited by 46
“Although infiltrating immune cells are known to be involved in HCC initiation and progression, the plethora of inflammatory cytokines up-regulated in human HCC have confounded the identification of individual key cytokines to target for therapy.((22-25)) FIG.”
BackgroundModerate Exercise Inhibits Age-Related Inflammation, Liver Steatosis, Senescence, and Tumorigenesis
Bianchi, A., Marchetti, L., Hall, Z., Lemos, H., Vacca, M., Paish, H., Green, K., Elliott, B., Tiniakos, D., Passos, J. F., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001022 · Cited by 45
“The model is also characterized by severe chronic hepatic and gastric disease that spontaneously progresses to cancer (14, 19).”
BackgroundSelf-citationThe Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers
Korbecki, J., Bosiacki, M., Barczak, K., Łagocka, R., Chlubek, D., & Baranowska‐Bosiacka, I. (2023) · Cells · doi:10.3390/cells12101406 · Cited by 52
“In liver cells, there is p50:p50 NF-κB [120], which”
BackgroundMahmud, Z., Rahman, A., Mishu, I. D., & Kabir, Y. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10024-8 · Cited by 46
“Bergers et al. showed that MMP2 and MMP9 are upregulated in angiogenic lesions, promoting tumor 1 3 Table 1 Mechanistic explanations of the role of neutrophils in pro-tumorigenic behaviors of cancer Role Mechanism Cancer type Model Ref Carcinogenic ROS and NO released by neutrophils cause DNA damage which results in o…”
BackgroundInfluentialA pro-tumorigenic function of S100A8/A9 in carcinogen-induced hepatocellular carcinoma
Ponti, A. D., Wiechert, L., Schneller, D., Pusterla, T., Longerich, T., Hogg, N., Vogel, A., Schirmacher, P., Heß, J., & Angel, P. E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.09.005 · Cited by 40
“These results are consistent with previous findings that CXCL1 is induced in transgenic mice with ectopic S100a8 and S100a9 expression in the liver [29], and reduced in S100a9−/− tumor-bearing livers [30].”
BackgroundResultJílková, Z. M., Kuyucu, A. Z., Kurma, K., Pour, S. T. A., Roth, G. S., Abbadessa, G., Yu, Y., Schwartz, B. E., Stürm, N., Marche, P. N., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24298 · Cited by 47
Ji, J. H., Ha, S. Y., Lee, D., Sankar, K. N., Koltsova, E. K., Abou‐Alfa, G. K., & Yang, J. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087640 · Cited by 38
de Valle, E., Grigoriadis, G., O’Reilly, L. A., Willis, S. N., Maxwell, M. J., Corcoran, L. M., Tsantikos, E., Cornish, J., Fairfax, K. A., Vasanthakumar, A., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151182 · Cited by 37
“Our data support a model in which p50NFκB1 homodimers repress Il-6 transcription in mature Fo B cells, which is consistent with p50-NFκB1 homodimers and histone deactylase 1 being constitutively bound to the Il-6 promoter in certain cell lines (Zhong et al., 2002; Wilson et al., 2015).”
ResultHigh CYP2E1 activity correlates with hepatofibrogenesis induced by nitrosamines
Gao, J., Wang, G.-J., Wang, Z., Gao, N., Li, J., Zhang, Y.-F., Zhou, J., Zhang, H., Wen, Q., Jin, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22937 · Cited by 41
“Although some previous studies suggested that CYP2E1 plays a crucial role in hepatic injury, CYP2E1 content rather than CYP2E1 activity was typically measured and linked to liver injury [32, 33].”
ResultConsidering Abundance, Affinity, and Binding Site Availability in the NF-κB Target Selection Puzzle
Brignall, R., Moody, A. T., Mathew, S., & Gaudet, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00609 · Cited by 37
Moles, A., Butterworth, J. A., Sanchez, A. M., Hunter, J. E., Leslie, J., Sellier, H., TINIAKOS, D. G., Cockell, S., Mann, D. A., Oakley, F., et al. (2016) · Oncogene · doi:10.1038/onc.2015.526 · Cited by 34
Self-citationWang, C., Shang, C., Gai, X., Song, T., Han, S., Liu, Q., & Zheng, X. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.631931 · Cited by 36
Li, X., Li, R., Miao, X., Zhou, X., Wu, B., Cao, J., Wang, C., Li, S., & Cai, J. (2024) · Inflammation · doi:10.1007/s10753-024-02026-1 · Cited by 33
“The top markers of MDSCs, including S100A8, S100A9, and S100A12, were involved in the nuclear factor-kappaB (NF-kappaB) signaling pathway, which plays a role in inflammation-induced HCC progression [37] and the formation of a neutrophil chemokine network with CXCL2 [38] (Fig.”
Sun, W., Xing, B., Guo, L., Liu, Z., Mu, J., Sun, L., Wei, H., Zhao, X., Qian, X., Jiang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep26499 · Cited by 29
Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
Rios, R. S., Zheng, K. I., & Zheng, M.-H. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001888 · Cited by 29
“Additionally, ROS production isn’t limited to byproducts of aerobic respiration, since macrophages and neutrophils are capable of employing ROS for their cytotoxic properties.([35]) Mitochondrial dysfunction can be interpreted as a response to the unhealthy environment faced by the hepatocytes in a fatty liver.”
BackgroundGuo, J., Chen, J., Lu, X., Guo, Z., Huang, Z., Zeng, S., Zhang, Y., & Zheng, B. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01144 · Cited by 27
Gao, J., Wang, Z., Wang, G., Gao, N., Li, J., Zhang, Y., Zhou, J., Zhang, H., Wen, Q., Jin, H., et al. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22851 · Cited by 28
Golonka, R. M., & Vijay–Kumar, M. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.004 · Cited by 29
S100A8 promotes migration and infiltration of inflammatory cells in acute anterior uveitis
Wang, Y., Zhang, Z., Zhang, L., Li, X., Lu, R., Xu, P., Zhang, X., Dai, M., Dai, X., Qu, J., et al. (2016) · Scientific Reports · doi:10.1038/srep36140 · Cited by 26
Inflammatory processes involved in NASH-related hepatocellular carcinoma
Cannito, S., Dianzani, U., Parola, M., Albano, E., & Sutti, S. (2023) · Bioscience Reports · doi:10.1042/bsr20221271 · Cited by 31
Chemokines as Regulators of Neutrophils: Focus on Tumors, Therapeutic Targeting, and Immunotherapy
Bonecchi, R., Mantovani, A., & Jaillon, S. (2022) · Cancers · doi:10.3390/cancers14030680 · Cited by 29
Wang, X., Li, X., Wu, Y., Hong, J., & Zhang, M. (2023) · BMC Cancer · doi:10.1186/s12885-022-10492-9 · Cited by 26
Cartwright, T. N., Worrell, J. C., Marchetti, L., Dowling, C. M., Knox, A., Kiely, P., Mann, J., Mann, D. A., & Wilson, C. L. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.09.001 · Cited by 25
“A major focus for our laboratory has been the functions of the p50 NF-κB subunit expressed from the NFKB1 gene and in particular its distinct role when operating without RelA as a dimer partner [3].”
BackgroundInfluentialSelf-citationElevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
Meng, J., Gu, F., Fang, H., & Qu, B. (2019) · Journal of Cancer · doi:10.7150/jca.28409 · Cited by 25
“Previous investigations indicated that S100A9 was overexpressed in HCC tissues and could promote HCC cell growth and invasion through RAGEdependent MAPK signaling cascades [18-20].”
BackgroundThe NF-κB1 is a key regulator of acute but not chronic renal injury
Fearn, A., Situmorang, G. R., Fox, C. P., Oakley, F., Howarth, R., Wilson, C. L., Kiosia, A., Robson, M. G., Mann, D. A., Moles, A., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.233 · Cited by 25
“21 Here we investigate the role of NF-κ B1 in NTS-induced GN mouse model.”
Self-citationDiethylnitrosamine Induction of Hepatocarcinogenesis in Mice
Sotty, J., Bablon, P., Weiss, P.-H., & Soussan, P. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3694-7_2 · Cited by 22
Dysfunctional Mechanism of Liver Cancer Mediated by Transcription Factor and Non-coding RNA
Zeng, W., Wang, F., Ma, Y., Liang, X., & Chen, P. (2018) · Current Bioinformatics · doi:10.2174/1574893614666181119121916 · Cited by 19
The Biological Function of Kupffer Cells in Liver Disease
Ma, Y., Yang, M., He, Z., Wei, Q., & Li, J. (2017) · InTech eBooks · doi:10.5772/67673 · Cited by 25
Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC
Beudeker, B. J. B., Groothuismink, Z. M. A., van der Eijk, A. A., Debes, J. D., & Boonstra, A. (2022) · Cancers · doi:10.3390/cancers14194900 · Cited by 19
The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network
Volponi, C., Gazzillo, A., & Bonavita, E. (2022) · Cancers · doi:10.3390/cancers14246151 · Cited by 24
Harnessing neutrophil plasticity for HCC immunotherapy
Ramon‐Gil, E., Geh, D., & Leslie, J. (2023) · Essays in Biochemistry · doi:10.1042/ebc20220245 · Cited by 22
Yang, D., Zhang, W., Liang, J., Ma, K., Chen, P., Lu, D., & Hao, W. (2017) · Oncotarget · doi:10.18632/oncotarget.23587 · Cited by 21
Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated Mice
Gee, L. M. V., Barron-Millar, B., Leslie, J., Richardson, C., Zaki, M. Y. W., Luli, S., Burgoyne, R. A., Cameron, R. I. T., Smith, G. R., Brain, J. G., et al. (2023) · The American Journal of Pathology · doi:10.1016/j.ajpath.2022.09.005 · Cited by 18
Self-citationLiu, G., Wang, Q., Deng, L., Huang, X., Yang, G., Cheng, Q., Guo, T., Guo, L., Niu, C., Yang, X., et al. (2022) · Theranostics · doi:10.7150/thno.65916 · Cited by 18
“It has been reported that the Cxcl1 and S100a9 promoters are repressed by p50:p50 homodimers complexed with HDAC1 [30].”
BackgroundKolluri, A., Li, D., Li, N., Duan, Z., Roberts, L. R., & Ho, M. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000022 · Cited by 19
Xiao, Q., Fu, B., Chen, P., Liu, Z. Z., Wang, W., & Ye, Q. (2016) · Medicine · doi:10.1097/md.0000000000005609 · Cited by 17
Assembly of vascular smooth muscle cells in 3D aggregates provokes cellular quiescence
Jäger, M. A., Torre, C. D. L., Arnold, C., Kohlhaas, J., Kappert, L., Hecker, M., Feldner, A., & Korff, T. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111782 · Cited by 17
Innate immune cells and their interaction with T cells in hepatocellular carcinoma (Review)
Hong, G., Cai, D., Gong, J., & Lai, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.12319 · Cited by 20
“In addition, neutrophil‐mediated reac‐ tive oxygen species production and telomere DNA damage contributed to the development of HCC and NF‐κB1 weakened the protumoral effect of neutrophils in diethylnitrosamine induced murine models (53).”
BackgroundOrganotypic Modeling of the Tumor Landscape
Haykal, M. M., Nahmias, C., Varon, C., & Martin, O. C. B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.606039 · Cited by 19
Case Report: A Novel Mutation in NFKB1 Associated With Pyoderma Gangrenosum
Fang, R., Wang, J., Jiang, X.-Y., Wang, S., Cheng, H., & Zhou, Q. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.673453 · Cited by 18
Metadata
- Authors
- Wilson, C. L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A. M., Gieling, R. G., Chakraborty, J. B., Fox, C., Richardson, C., Callaghan, K., Blair, G. E., Fox, N., Lagnado, A., Passos, J. F., Moore, A. J., Smith, G. R., Tiniakos, D. G., Mann, J., Oakley, F., & Mann, D. A.
- Affiliations
- Newcastle University (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Manchester (GB)
- Hammersmith Hospital (GB)
- University of Leeds (GB)
- Corresponding author
- Oakley, F.
- Mann, D. A.
- ORCID
- Venue
- Nature Communications
- Published
- 2015-04-16
- Volume
- 6
- Issue
- 1
- Pages
- 6818-6818
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4410629
- OpenAlex
- W2107718568
- Cited by
- 171
- References
- 58
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 14 · 2023: 24 · 2022: 23 · 2021: 21 · 2020: 20 · 2019: 7 · 2018: 19 · 2017: 12 · 2016: 13 · 2015: 3
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-09-21)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, cc-by)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Northumbria Research Link (Northumbria University) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust (G0900535, WT086755MA, 087961)
- Cancer Research UK
- Newcastle University
- European Commission (223151)
- University of Adelaide
- Medical Research Council (G0900535, MR/K006312/1, MR/K0019494/1, M501700, G0700890, MR/K001949/1)
- Biotechnology and Biological Sciences Research Council (BB/K017314/1, BB/H022384/1)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- NFKB1, hepatocellular carcinoma, neutrophils, tumor microenvironment, HDAC1, S100A8/S100A9, CXCL1, CXCL2, neutrophil chemokines, reactive oxygen species, chronic liver disease, aging, diethylnitrosamine, tumour suppressor, neutrophil depletion
- MeSH terms
- Alkylating Agents, Animals, Diethylnitrosamine, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Experimental, Mutation, Neutrophils, Mice, Knockout, Calgranulin A, Calgranulin B, Mice, NF-kappa B p50 Subunit, Chemokine CXCL1, Chemokine CXCL2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.